Santarus
A specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists.
Launch date
Employees
Market cap
-
Enterprise valuation
€2.4b (Public information from Nov 2013)
San Diego California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | Early VC | |
$4.8m | Series B | ||
$33.2m | Series C | ||
$51.4m | Series D | ||
| N/A | $54.0m Valuation: $255m | IPO | |
$2.6b Valuation: $2.6b | Acquisition | ||
| Total Funding | €81.3m | ||